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The genus  Origanum is a group of phytochemically diverse, aromatic species. Distributed mainly in
Eurasia and Mediterranean, they are used in traditional medicine, cosmetics and for culinary purposes.
They possess antiproliferative,  antioxidant, antiviral,  antiseptic, anti-inflammatory, anti-hypertensive
properties.  The major constituents  of  Origanum spp. are  carvacrol  and/or thymol  together  with γ-
terpinene, p-cymene, linalool, terpinene-4-ol and sabinene hydrate. Several flavonoids and glycosides
are also found.  Although the  Origanum spp. can either be cultivated or sourced from nature, high
demand has necessitated increased production. Overexploitation from natural habitat has threatened
these  species.  Also,  due  to  its  poor  viability  and  small-sized  seeds,  cross-pollination  abilities,  less
productive  vegetative  propagation,  climate-dependent  conventional  propagation,  its  genetic
improvement  has  been  limited  and  thus  scientific  management  of  available  germplasms  through
biotechnological  approach  is  necessary.  For  in-vitro propagation,  the  literature  review  showed
significant differences in culture protocols, genotypes and their success rates.  Studies reported cell
culture-based  production  of  secondary  metabolites  or  isolation  of  active  compounds  in  different
species of Origanum, which show antiproliferative activity in cancerous cell lines. However, significant
knowledge  gaps  exist.  The  urgent  need  is  to  use  advance technologies  in  enhancing  either  plant
propagation thus the production of source material for active constituents or for genetic improvement
of  Origanum germplasms for contents, as well as to validate the therapeutic potential of  Origanum
constituents. This  review  critically  appraises  the  status  of  mostly  underexploited  biotechnological
know-how and research on highly valued medicinal herbs, Origanum and throws light on prospects and
potential.
Introduction
The  term  “traditional  medicine”  is  used
interchangeably  with  complementary  or  alternative
medicine  (CAM)  which  broadly  includes  herbal
medicine and natural  medicine (1).  Worldwide,  60 -
80% of people depend on traditional herbal medicine
for  their  healthcare,  body  care  and  food  products,
leading to an increased demand for medicinal  plant
material  (2,  3).  Many  of  the  medicinal  plants
containing aromatic essential oils are used not only as
traditional  medicines  but  also  in  food,  flavour  and
fragrance industry (2).
The  genus  Origanum  L.,  belonging  to  family
Lamiaceae,  tribe  Mentheae  comprises  of  forty-nine
taxa including 38 species, 6 subspecies, 3 varieties and
remaining  hybrids  and  is  characterized  by  vast
taxonomic,  morphological,  anatomical  and  chemical
diversity.  The  Origanum species  are  annual  or
perennial, shrubby herbs grown and naturally found
across  many  geographical  regions.  In  spite  of  the
multi-purpose medicinal, culinary and cosmetic value
of the  Origanum  species,  only less than 50% species
have  been  subjected  to  chemical  profiling,
characterization and biological studies (4).
Distribution
Origanum populations  are  primarily  distributed  in
Eurasia  and  African  regions.  They  have  the  highest
recorded  diversity  in  the  Mediterranean,  Euro-
Siberian  and  Irano-Siberian  regions  (5).  Origanum
species  are  found  on  stony  slopes  and  in  rocky
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mountain areas at a wide range of altitudes (0–400 m)
(6). With reference to biotechnological interventions,
two  Origanum  species  are,  however,  worth  special
mention.  Origanum vulgare  L., commonly known as
Oregano, wild marjoram, Himalayan marjoram, or as
Ban  tulsi  or  Jangli  Marwa  in  India,  is  widely
distributed  in  Mediterranean  areas  and  Northern
Africa  and  in  India,  found  in  the  temperate
Himalayas from Kashmir to Sikkim at an altitude of
1500–3600 m (4, 5). Origanum majorana L., commonly
known  as  Marjoram,  Sweet  Marjoram,  Knotted
Marjoram,  Sampsishia  or  as  Marwa  in  India,  is
although endemic to Cyprus, cultivated all over Asia,
Arabian  Peninsula  and  Africa  (4)  and  is  found  in
Europe as well (7). Both Oregano and Marjoram are
one of the most important and largest selling culinary
herbs (8).
Uses
Origanum spp. have been used as herbal medicine, in
aromatherapy  and  as  a  culinary  herb,  spice  and
flavouring  agent  in  food,  across  many  nations  and
cultures (9). In traditional Indian medicine, medicinal
properties of  O. majorana were known (10). Various
medicinal,  culinary, cosmetic and other uses (11–34,
45, 46) of  Origanum spp.  have been summarized in
Fig.  1.  Whether  used  as  an  essential  oil,  leaves
extract, powder, fresh or dried leaves, marjoram has
numerous health benefits (35, 36).
Phytoconstituents
The  Origanum  biotypes  vary  in  respect  of  content
and/or  composition  of  essential  oil  in  them  (36).
Essential  oil  ‘rich’  species  with  an  essential  oil
content of >2%, is mainly characterized either by the
dominant  presence  of  carvacrol  and/or  thymol
(together  with  γ-terpinene  and  p-cymene)  or  by
linalool,  terpinene-4-ol  and  sabinene  hydrate  as
principal  components  (37–39).  Besides  the  presence
of  essential  oil,  different  qualitative  phytochemical
tests  exhibited  the  presence  of  flavonoids,  tannins,
glycosides,  cardiac  glycosides,  sterols,  terpenoids  in
ethanol extract of leaves, root and stem and saponins
and  carbohydrates  in  aqueous  extracts  (40).
Considerable  amounts  of  phenolic  compounds  are
generally available in water, methanol,  acetone and
ethylacetate/water  extract  of  Origanum (11).  The
phytochemical  constituents  of  O.  majorana  were
extensively reviewed (36). Some phenolic glycosides
found in marjoram essential oil are Arbutin, Methyl
arbutin  and  Vitexin.  Among  flavonoids,  Hesperetin
has been identified in ethyl acetate extract; Catechin,
Quercetin,  Kaempferol,  Naringenine and Eriodictyol
in  the  hydroalcoholic  extract  and  flavonoids  like
Diosmetin,  Luteolin  and  Apigenin  are  found  in
marjoram  essential  oil  (41–43).  Rutin,  a  flavonoid
glycoside was identified in marjoram hydroalcoholic
extract  (44).  Besides  having  Rutin,  Quercitin  and
Eugenol in aerial parts, which give it an advantage as
a  flavouring  agent,  O.  majorana  particularly  has
nutritional  benefits  as  well.  Nutritive  analysis  of
dried  leaves  yields:  energy,  carbohydrates,  fat,
dietary  fibre;  Vitamins-  folate,  niacin,  pantothenic
acid,  pyridoxine,  riboflavin,  thiamin,  vitamin-A,
vitamin-C, vitamin-E, vitamin-K; Electrolytes- sodium,
potassium;  Minerals-  calcium,  copper,  iron,
magnesium, manganese, zinc; and Phytonutrients, ß-
carotene, ß-cryptoxanthin, lutein-zeaxanthin (45).
Propagation Means
Increasing demand for Origanum spp. in the pharma,
perfumery  and  cosmetic  industry  has  necessitated
their  large  scale  production.  Increases  in
consumption in recent years may be due in part to
the popularity of low-fat, low-salt diets (46). Whether
vegetative  parts  (both  green  and  dry),  extracts  or
essential oil are used (47, 48), it necessarily requires
better propagation means to make larger quantities
of source material available.
Origanum species are either sourced from its
natural occurrence in the wild or cultivated. Though
they  are  half-hardy  perennial  sub-shrubs,  they  are
treated as annual herb under cultivation. In nature, it
is found growing on hill-sides and also on limestone
and calcareous rocks. When cultivated,  propagation
is  either  via  seeds  or  vegetative  means  (49).
Vegetatively, Origanum species can be propagated by
cuttings,  division  or  by  layering.  Under  cultivation,
they  generally  require  dry,  warm,  well-drained
fertile  garden  loamy  soil  and  frequent  watering.
However, it grows well under wide pH ranges from
acidic,  neutral  to  basic  soils  (7).  Marjorams  are
generally cold-sensitive frost-tender herbs and can be
grown  outdoors  as  annuals  and  replanted  in  the
spring.  In plains,  seeds are sown in October and in
the hills from March to June (50). In contrast, at the
higher elevation, sometimes propagation is done by
cutting. Seeds can be sown in pots initially and then
transplanted in the field. The crop is harvested in 3–4
months. The tops are cut at the time of flowering and
dried  in  the  shade.  The  volatile  oil  content  of  the
leaves  is  maximum  when  the  plant  is  harvested
before  seed  formation.  The  flowers  are
hermaphrodite and are pollinated by bees (7).
Though  the  Origanum sp.  can be  cultivated
and  material  can  be  sourced  from  its  natural
occurrence  also,  every  cultivation  and  sourcing
method has its problems. For example,  propagation
via seeds has a considerable disadvantage- as a cross-
pollinating  plant,  the  offspring  of  seeds  represent
populations  differing  in  habit,  colour,  content  and
odour  of  the  essential  oil  (51).  Secondly,  growing
Oregano  from  seed  is  not  always  reliable  as  seeds
have a long dormancy and they germinate poorly if
proper  temperature  and  moisture  conditions
following  dormancy  are  not  met  (49).  In  its
vegetatively propagated taxa, the poor rooting ability
of the stem cuttings and thus non-significant survival
efficiency  (52)  and  lack  of  selected  clones,  restrain
industrial exploitations (53). 
On the other hand, sourcing large quantities of
the  plants  material  for  the  preparation,  processing
and testing of the product and thus overexploitation
from natural resources are acting negatively on the
populations  of  the  plant  and  such  activities  have
brought the species at the verge of being endangered.
There  is  a  strong  need  for  the  application  of
biotechnological  techniques  for  multiplication  and
conservation of  Origanum species (54)  as well  as to
promote  and  popularize  this  wealth  among  the
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farmers, entrepreneurs and pharmaceutical industry
(53).
Biotechnological Interventions
Tissue culture efforts in Origanum vulgare started as
early as 1970. A report, while studying the formation
of  volatile  substances  in  plant  tissue  cultures,
achieved  callus  induction  from  stem  segments  of
field-grown  O.  vulgare,  on  MS  media  (55)
supplemented with different auxins -IAA, NAA or 2,4-
D (56). Tissue differentiation leading to regeneration
was achieved;  however,  much later  –  in  O. vulgare
(57)  and  O.  majorana  (58).  The  biotechnological
efforts  put  in  the  species  of  Origanum  has  been
discussed  here  under  these  sections:  Plant
regeneration  in  Origanum species;  Callus  and  cell
suspension  culture  for  production  of  secondary
metabolites;  Genetic  transformation;  and
Antiproliferative  properties:  effects  of  extracts/
preparations from  Origanum  species on cytotoxicity
of cancer cells.
Plant Regeneration in Origanum spp.
In-vitro plant  regeneration  has  been  achieved  in
many  species  of  Origanum.  If  not  all,  most  of  the
studies  resorted  to  getting  regeneration  from  pre-
existing  meristems  (PEMs)  and  very  few  reports
claim  to  have  morphogenesis  in  dedifferentiated
cells.  A  comparative  and  summarized  view  of
explants,  basal  culture  media  and  plant  growth
regulators  combination  tested  for  in-vitro
regeneration  in  different  species  of Origanum
reported till date is presented in Table 1.
Plant Materials:
Explants  from various  plant  parts-  either  young or
mature  seedlings  or  mature  plant  body,  mostly
containing  PEMs,  have  been  utilized  to  achieve  in-
vitro plant  regeneration in  many  Origanum species
(51–54, 57–71, 74). 
Surface Sterilization: 
In  Origanum tissue  culture,  wherever  seeds  or
seedlings  parts  have  been  used  as  explants,  seeds
have  been  surface-sterilized,  subjected  to
germination  and  then  explants  from  axenically
grown seedlings have been harvested. In O. vulgare,
O.  majorana, O.  sipyleum L.  and  O.  syriacum  L.,
mostly  the  first  step  is  washing  the  mature  seeds
either  with  50–70%  ethanol  or  with  0.01–0.2%
fungicide,  followed  by  treatment  with  sodium
hypochlorite,  or  mercuric  chloride  or  other
disinfectants  with  varying  concentration  and  time
and then washing with sterile water to remove traces
of disinfectants (54, 57, 58, 62, 65, 70, 74). The surface-
sterilized seeds were germinated on either 0.8% agar
or half  or full-strength MS medium with 2% or 3%
sucrose.  In  O.  minutiflorum Schwarz  &  Davis,  O.
acutidens (Hand.-Mazz.)Ietsw.  and  O.  onites L.,
however, seeds were only treated with 5–15% NaOCl
followed  by  3-5  washes  with  water,  before  putting
them for germination in MS or Gamborg B5 medium
in the dark or in the presence of light (67, 68, 71). 
Wherever  Origanum explants  were taken from
mature or naturally  grown plants,  plant parts were
PLANT SCIENCE TODAY  514
Fig. 1. Various uses of Origanum spp. References are given in parentheses.
first washed with either a detergent or with 50%, 70%
or 95% ethanol followed by treatment with 1.5 –2.0%
or 5–10 % NaOCl or 5% Ca(ClO)2 or sometimes with
0.1 % HgCl2 solution for few minutes to disinfect the
tissues  followed by several  washes  with water  and
before  preparing  the  explants  for  inoculation  [O.
majorana (59–61); O. vulgare (64, 72); O. sipyleum (66);
O. syriacum and O. ehrenbergii Boiss. (69)]. In one of
the reports, however, only a fungicide was used as a
surface sterilant after washing with detergent for  O.
majorana stem nodal segments (52). 
Basal Media and Media Addenda:
Tissue culture  efforts  on  Origanum spp. for  in-vitro
plant regeneration mostly used MS medium as basal
medium  and  supplemented  this  medium  with
different  plant  growth  regulators  (PGRs)  or  other
addenda. Other media formulations like Gamborg-B5
medium (75), Nitsch and Nitsch medium (76), Phillips
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Table 1. Studies on In-vitro culture/Plant Regeneration and Callus/ Cell Suspension Culture in Origanum spp.
S. No. Explant Basal media PGR combinations Reference
In-vitro culture / Plant regeneration
O. majorana
1
Shoot tips and nodal segment from 30-
60 d old seedlings
MS 0.5 mg/L Kin. (58)
2 Stem nodal Segments MS 0.1 , 10.0 mg/L BAP; 0.1 mg/L IBA (59)
3 Stem nodal segments and Leaf MS with Sucrose/Maltose/
Glucose
0.1, 0.2 mg/L 2,4-D; 2, 3 mg/L BAP ; 0.2 mg/L IBA (60)
4 Axillary buds MS 2 mg/L Kin. , 2 mg/L BAP (61)
5 Stem nodal segments MS / P&C L2 9.3 uM Kin. (52)
6 Hypocotyl and seed explants MS 2 mg/L 2,4-D and 0.5 mg/L Kin. ; 4 mg/L NAA and 
0.4 mg/L BAP
(74)
7 Cotyledonary node from seedlings MS 1mg/L BAP (62)
O. vulgare
1 Cotyledon, hypocotyl and root from 15 d
old axenic seedlings
B5 2,4-D at 10-7 M ; NAA with BAP at 10-6 M (57)
2 Shoot tips and nodal segments from 30-
60 d old seedlings
MS 1.0 mg/L BAP and 0.5 mg/L IBA (58)
3 Young shoot tips from field-grown 
plants
MS 0.53 uM NAA and 0.28 uM BAP (64)
4 Apical buds from in-vitro grown plants MS 8.88 uM BAP and 2.26 uM 2,4-D (53)
5 Hairy root segments MS 0.25 mg/L 2,4-D; 0.25 mg/L BAP (65)
O. vulgare ssp. hirtum
1 Nodal segments B5 0.01 mg/L NAA (63)
2 Stem tips from 1 wk. old seedlings Lepoivre nutritional 
Environment L4 and L11
0.15 mg/L IAA (51)
O. sipyleum
1 Shoot tips from 17d old seedlings
Modified MS with 550 mg/
L CaCl2
1mg/L BAP; 0.5 mg/L BAP (54)
2 Nodes from native plants MS 0.5 mg/L BA ; 0.2 mg/L GA3 ; 1.5 mg/L IBA (66)
O. syriacum
1 Stem nodal segments MS 2 mg/L BAP ; 0.5 mg/L IBA (69)
2 Shoot tips and 1st nodes from 25 d old 
seedlings
MS 0.05 mg/L NAA and 0.5 mg/L Kin. ; 1.5 mg/L IBA (70)
O. minutiflorum
1
Nodal segments and shoot tips from 30-
40 d old plants
MS / B5 2 mg/L BAP and 0.1 mg/L NAA (67)
O. acutidens
1 Node explants from 1 wk. old seedlings MS 1.8 mg/L BAP and 0.2 mg/L NAA (68)
O. onites
1
Hypocotyl, epicotyl, cotyledons, 
primary leaves and apical meristem 
from 4 wk. old seedlings
MS 1.5 mg/L Kin. (71)
O. ehrenbergii
1 Stem nodal segments MS 2 mg/L BAP ; 0.5 mg/L IBA (69)
Callus and cell suspension culture for production of secondary metabolites
O. vulgare & O. syriacum
1 Leaf MS 0.1-0.5 mg/L 2,4-D; 1-1.5 mg/L TDZ (72)
O. vulgare, O. vulgare ssp. hirtum & O. syriacum
2 Leaf MS / LS / B5 0.5 mg/L 2,4-D and 5 mg/L Kin. ; 0.5 mg/L NAA and 
3 mg/L BAP
(73)
Abbreviations: d: days; BM: Basal Media; MS: Murashige and Skoog Medium; P&C L2: Philips and Collins L2 medium; B5: Gamborg-B5 
medium; LS: Linsmaier and Skoog medium; N&N: Nitsch and Nitsch medium; Kin.: Kinetin; BAP: Benzyl Amino Purine; IBA= Indole-3-
Butyric Acid,; IAA: Indole-3-Acetic Acid; NAA: α-Naphthalene Acetic Acid; 2,4-D: 2,4- dichloro-Phenoxy Acetic Acid; GA3: Gibberellic Acid, 
TDZ: Thidiazuron.
and Collins (L2) medium (77) were also used to test
the explants’ response for regeneration. 
Various PGRs have been used in tissue culture of
species of Origanum. For shoot organogenesis, mostly
BAP  either  alone  or  in  combination  with  other
cytokinins like Kinetin or auxins  (IBA, IAA, NAA or
2,4-D)  have  been tested.  However,  other  cytokinins
like 2iP, Zeatin, Adenine sulphate and TDZ have also
been  used.  For  rooting,  IBA  has  been  the  most
preferred choice,  although other auxins like IAA or
NAA have also been used. Interestingly, GA3 was also
tested for shoot organogenesis in case of O. majorana
by one work (52) and in O. sipyleum by other (66). Use
of other media supplements like amino acids, casein
hydrolysate,  citric  acid,  ascorbic  acid  or  activated
charcoal was largely not found in the literature for
Origanum spp.  tissue  culture.  In  our  study  on  O.
majorana in-vitro regeneration (unpublished data), it
was found that the use of activated charcoal reduces
polyphenolics and controls browning of the medium,
thereby aiding shoot organogenesis. In one work (70),
thiamine,  glutamine  and asparagine  were tested as
media additive for  O. syriacum cultures,  and it  was
found  that  only  thiamine  supported  better  shoot
organogenesis.
Carbon Source:
Sucrose has been used as a carbon source by most of
the researchers to accomplish plant regeneration in
different  species  of  Origanum. While  3%
concentration of sucrose has been shown to be apt by
most,  2%  sucrose  was  used  by  one  (59).  Three
different carbon sources were tested for O. majorana
(60), and it was found that 3% maltose was best for
supporting shoot organogenesis. 
Gelling agents:
In  all  the  reports  on  tissue  culture  of  various
Origanum species, agar has been used invariably as a
gelling agent. Whereas a concentration of 0.8% agar
has  been most  common,  some have  used  different
concentrations as well: 0.6% agar for O. minutiflorum
(67), 0.62 % agar for  O. acutidens cultures (68), 0.7%
agar  for  culturing  O.  syriacum explants  (70)  and
0.75%  agar  for  achieving  shoot  regeneration  in  O.
sipyleum (66). Use of Gelrite or Phytagel as a gelling
agent  was  not  found  in  the  published  reports  on
Origanum.  This  is  interesting  as  the  production  of
phenolic  acids  was  demonstrated  in  O.  majorana
cultures  (62).  As  Gelrite  is  known for  its  ability  to
leach  out  polyphenolics  exuded  by  plant  tissues  in
culture  and thus reducing harmful  effects  on plant
regeneration, it must be tested as a gelling agent for
Origanum tissue culture with an imperative to obtain
a better morphogenic response. 
Culture Conditions: 
Origanum  spp.  tissue  cultures  are  incubated  at  a
temperature of 25±2 C and a photoperiod of 16 hrs,⁰
under white fluorescent light in most of the reports.
Some have, however utilized a photoperiod of 12 hrs
for  O.  majorana  (58–60)  and  O.  vulgare (57,  58)
cultures and one work (74) used a photoperiod of 10
hrs for O. majorana cultures. Different temperatures
have also been used: 28±1 C (57), 2⁰ 2  C (64) and 26 C⁰ ⁰
(65) to O. vulgare cultures. A temperature of 26±2 C⁰
was used by one study (69) to  O. syriacum L. and  O.
ehrenbergii Boiss.  cultures,  while  other  (51)  used  a
temperature  of  28±1  C  to  ⁰ O.  vulgare ssp.  hirtum
(Link) Ietsw. cultures.
Approaches in In-vitro regeneration of Origanum:
In  almost  all  in-vitro regeneration  reports  on  any
species  of  Origanum,  organogenesis  has  been  the
regeneration  mode.  The  shoot  organogenesis  has
been mostly achieved from PEMs- either from shoot
apex  or  from  axillary  buds.  The  reports  where
indirect  organogenesis  from  dedifferentiated  cells
has been achieved are scanty [in O. majorana (52, 60);
in  O. vulgare  (57, 65)]. Recently, it was reported that
in  O.  onites  L.,  all  explants  except  shoot  apical
meristem  (SAM)  developed  into  non-morphogenic
calli  and  did  not  show  any  regeneration  (71).
Organogenesis is a function of a group of cells having
their division products set in fashion to differentiate
in a particular organ, which in turn is preceded by
meristemoid  formation.  Meristem  organization  is,
therefore, very tightly regulated in  Origanum  and it
neither  disorganizes  easily  nor  reforms  (from
dedifferentiated  cells)  easily.  Regeneration  via
somatic  embryogenesis  is  not  reported,  till  date,  in
any  species  of  Origanum.  This  also  opens  up  new
opportunities  for  researchers  to  understand  plant
regeneration in this important medicinal herb.
Although  in-vitro plant  regeneration  has  been
demonstrated  in  many  species  of  Origanum,  two
types of efforts may be categorized: (a) those where
explants  are  from  young  seedlings-  like  cotyledon
segments, hypocotyl pieces,  cotyledonary node, root
segments  or  shoot  tips  possessing  or  devoid  of  an
organized  or  mature  meristem,  (b)  those  where
explants  are  from  mature  plant  parts  possessing
PEM– like shoot apical meristem, stem node, axillary
buds or leaves.
From seedling explants: 
In the pioneering study on  O. vulgare  (57), explants
were subjected  to  Gamborg-B5  medium with  2,4-D,
NAA  and  BAP  individually  and  in  various
combinations of 0, 0.1, 1 and 10 uM. It was found that
whereas callus proliferation was best at 0.1 uM 2,4-D,
cotyledon  explants  was  the  best  source  of  nodular
callus.  These  calli,  when  transferred  to  NAA  in
combination  with  1uM  BAP,  developed  the  highest
number  of  shoots.  The  best  rooting  of  shoots  was
achieved  on  half-strength  B5  medium  having  1%
sucrose and NAA or IBA at 1uM concentrations. Shoot
apices of  O. sipyleum were subjected to MS medium
with 550 mg/L CaCl2 and 1 mg/L BAP by one study
(54).  Multiple  shoots  were  obtained,  which  were
subsequently rooted in MS containing 0.5 mg/L IBA.
Node explants of  O. acutidens  were cultured on MS
medium  supplemented  with  0.2  mg/L  NAA  in
combinations with various BAP concentrations (0.6–
2.4  mg/L)  (68).  Better  shoot  organogenesis  was
observed in this work on a combination of 0.2 mg/L
NAA and 1.8 mg/L BAP. In another work (62), shoot
part including buds from O. majorana seedlings were
subjected  to  MS  with  3%  sucrose  and  various
concentrations  of  BAP  (0–1  mg/L).  The  maximum
number  of  shoots  was  obtained  with  1  mg/L  BAP.
They found that in O. majorana, the inclusion of BAP
in  medium  enhanced  the  number  of  shoots.  In
contrast, its omission from medium led to an increase
in the length of the regenerated shoots.
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A detailed  study  of  the  in-vitro response of  O.
syriacum explants  was  done  (70).  Explants  were
cultured on MS-, Nitsch and Nitsch- and Gamborg-B5-
media  with  3%  sucrose  for  establishment.  After
establishment, explants were subjected to MS with 1
mg/L of Kinetin, 2iP and BAP and further on various
levels (0–2 mg/L) of Kinetin. It was found that shoot
tip was best responsive explant and MS was the best
basal  medium  for  culturing  O.  syriacum explants.
Strikingly,  Kinetin  was  best-suited  cytokinin  and
shoots cultured on MS with 0.05 mg/L NAA and 0.5
mg/L Kinetin produced the highest amount of shoots.
The  highest  frequency  of  rooting  in  regenerated
shoots  was obtained on MS medium with 1.5  mg/L
IBA. A similar observation was recorded by another
study  recently  (71),  which  subjected  O.  onites
explants  to  MS  medium  with  varying  0.5-1.5  mg/L
Kinetin.  They  found  that  SAM  explants  gave  the
highest shoot organogenesis in 1.5 mg/L Kinetin.
From mature plant parts:
Both  O. majorana and  O. vulgare  were studied (58)
for  in-vitro regeneration  response  on  MS  medium
with various concentrations of auxins and cytokinins,
wherein  best  shoot  organogenesis  was  reported  on
0.5 mg/L Kinetin in  O. majorana  explants  and on a
combination of 1 mg/L BAP and 0.5 mg/L IBA in  O.
vulgare.  Stem nodal  segments  of  O. majorana  were
subjected  (59)  to  MS  having  2%  sucrose  and
supplemented  with  0.1–10.0  mg/L  BAP  for  axillary
shoot  induction.  It  was  found that  there  is  a  dose-
dependent  relationship  between  the  number  of
shoots  and  BAP  concentration,  as  the  maximum
number of shoot induction was obtained at 10 mg/L
BAP.  However,  the  length of  shoots decreased with
increasing the  concentration of  BAP and maximum
shoot  length  was  obtained  at  0.1  mg/L  BAP.  The
regenerated shoots rooted best on MS supplemented
with 0.1 mg/L IBA. Both stem nodal segments and leaf
explants from O. majorana were, however, tested on
MS medium with various concentrations of sucrose,
maltose  and  glucose  and  with  2  mg/L  BAP  for
regeneration in another study (60). It was found that
the  maximum  number  of  regenerated  shoots  per
node was obtained on 3% maltose with 2 mg/L BAP.
The calli obtained from stem and leaf explants on MS
with  3% maltose  augmented  with  various  levels  of
2,4-D (0.01–1.0 mg/L) were subjected to MS with BAP,
either  alone  or  in  combination  with  IBA,  IAA  and
Kinetin (0.1–10.0 mg/L). Whereas calli obtained from
leaf  did  not  regenerate,  maximum  shoot
organogenesis was observed in stem calli on MS with
3% maltose and a combination of 3 mg/L BAP and 0.2
mg/L  IBA.  Highest  induction  of  roots  in  the
regenerated shoots was observed in 0.2 mg/L IBA. In
another  study  on  O.  majorana  (52),  stem  nodal
explants were subjected to MS and Philips and Collins
L2  medium  supplemented  with  various
concentrations  of  auxins  (IAA,  IBA,  NAA)  or
cytokinins  (BAP,  Kinetin,  Adenine  sulphate,  2-i-P,
TDZ) or GA3 either alone or in combinations (IAA and
BAP,  IAA  and  Kinetin  and  IBA  and  Kinetin).  In
general, the P&C L2 medium was better than MS for
shoot  organogenesis  and  both  direct  and  indirect
organogenesis  was  observed.  The  presence  of
Adenine  Sulphate  in  medium  promoted  direct
proliferation of shoots from the nodal region, while
other  cytokinins  favoured  indirect  regeneration  of
shoots from the callus. The concentrations of 9.3 uM
Kinetin  (38  shoots)  and  13.3uM  BAP  (33.3  shoots)
showed  a  higher  number  of  shoots  from  calli.
Interestingly,  this  report  demonstrated  that  even
auxins  or GA3 alone  in the  medium could  promote
shoot  organogenesis  from  nodes,  although  in  low
numbers.  In  O.  minutiflorum,  nodal  segments  and
shoot  tips  were  tested  on  MS  and  Gamborg-B5
medium with combinations of BAP (0, 1, 2 or 3 mg/L)
and NAA (0, 0.1 or 0.5 mg/L) (67). MS with 2 mg/L BAP
and  0.1  mg/L  NAA  was  found  best  for  shoot
organogenesis  from  nodal  segments.  In  a  tissue
culture report (69) on O. syriacum and O. ehrenbergii,
nodal explants were cultured on MS with 1, 1.5 or 2
mg/L BAP and it was found that 2 mg/L BAP was most
suitable for shoot multiplication in these two species.
Nodes from native plants of  O. sipyleum were tested
on combinations of BAP (0.1, 0.5, 1.0 mg/L) and GA3
(0.1,  0.2 mg/L) in MS-based medium and 85% shoot
organogenesis  response  was  obtained  on  a
combination of 0.5 mg/L BA and 0.2 mg/L GA3 (66).
62.5 % of regenerated shoots rooted in MS medium
supplemented with 1.5 mg/L IBA.
Young shoot tips from field-grown O. vulgare
x  applii hybrid  were  cultured  on  MS  with
combinations of NAA (0.53, 5.3, and 5.83 uM) and BA
(0.28, 2.58, and 3.86 uM) in order to get regeneration
response (64). Highest shoot induction was observed
by them on NAA (0.53 uM) and BAP (0.28 uM). Shoots
with  axillary  buds  of  O.  vulgare ssp.  hirtum  were
subjected  to  Gamborg-B5  medium  with  0.01  mg/L
BAP (63) and shoot, and root induction was obtained
on  the  same  medium.  Apical  buds  from  in-vitro
grown  plants  of  O.  vulgare  were  reported  to  be
cultured  (53)  on  MS  medium  with  various
concentrations  of  BAP  (2.22  –  8.88  uM)  in
combination  with  either  2,4-D  (2.26  –  11.3  uM)  or
NAA (2.68 – 13.42 uM) and best shoot induction was
observed in MS with 8.88 uM BAP and 2.26 uM 2,4-D.
In a report (61) on  O. majorana,  axillary buds were
subjected to MS with Kinetin (1 – 3 mg/L) or BAP (1 –
3 mg/L). Highest (85%) shoot organogenesis response
was noticed by this report on MS with 2 mg/L Kin (30
shoots),  followed  by  MS  with  2  mg/L  BAP  (62%
response, 22 shoots).
All the in-vitro regeneration studies reported
so far in any species of Origanum thus point to some
of  the  generalizations:  Most  of  the  reports  utilized
organogenesis  as  chief  mode;  Both  direct
organogenesis from PEMs and indirect organogenesis
from  dedifferentiated  cells  are  reported,  but
regeneration from PEMs are more common; direct or
indirect  somatic  embryogenesis  has  not  been
achieved  for  any  species  of  Origanum.  Also,
protoplast isolation and culture or regeneration from
protoplasts  for  any  species  of  Origanum is  not
reported. Similar is the case of  in-vitro regeneration
from inflorescence or any flowering part like sepals
or petals. Anther culture, pollen culture, unfertilized
ovary  culture  or  production  of  haploids  and
regeneration  has  also  not  been  reported  in  the
published literature. 
Vitrification in Origanum tissue culture:
Vitrification  or  hyperhydricity  is  a  physiological
malformation  that  is  commonly  associated  with
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tissue  culture  of  many  plant  species  and  affects
regeneration frequency. Vitrification in tissue culture
of O. vulgare and strategy to rectify this problem with
the  help  of  bacteria  isolated  from  oregano
rhizosphere (Pseudomonas spp.) was reported (79). A
plant-microbe  (O.  vulgare  -Pseudomonas  spp.)
interaction  that  prevents  physiological
malformations  associated  with  vitrification  was
suggested  (79).  Morphological  and  physiological
variations such as water content, chlorophyll content,
and total phenolics were compared between vitrified
and unvitrified clones. Unvitrified shoots were found
to have lower water content and higher chlorophyll
and total phenolics compared with vitrified controls.
In a further study (80), it was identified that out of
several  different  isolated  strains  of  Pseudomonas
spp.,  mucoidal  strains  A  and  F  prevented
hyperhydricity in O. vulgare cultures in a better way.
Shoots  inoculated  with  the  non-mucoid  strain-NMF
showed hyperhydricity and had very similar levels of
chlorophyll,  solids  and  phenolics  as  uninoculated
control. Later, hyperhydricity prevention in Oregano
by  several  nonspecific  polysaccharides  producing
rhizosphere  bacteria,  including  Pseudomonas
mucidolens and  another  Pseudomonas sp.  was  also
shown  (81).  The  endophytes  and  rhizospheric
bacteria  of  O.  vulgare were  shown to  possess  high
anti-oxidant  and  plant  growth-promoting  activities
and  to  produce  several  hydrolytic  enzymes  (82).
However,  for  commercial  micro-propagation  of
Origanum spp.,  vitrification  in  organogenesis-based
in-vitro regeneration  methods  remains  a  problem.
Deploying bacteria to prevent this hyperhydricity is
still far from any practical utility. 
Callus and cell suspension culture for production 
of secondary metabolites
Two  studies  reported  the  development  of  callus
and/or cell suspension culture in a few Origanum sp.
(Table 1) and compared the presence and amounts of
active  constituents  from  their  mature  plant
counterparts (72, 73). Leaf explants from  O. vulgare
and  O.  syriacum were  cultured  on  MS  medium
supplemented with various levels of 2,4-D (0–2 mg/L)
to  develop  callus  cultures  (72).  Callus  maintenance
was tested on different levels of BAP or TDZ (0.5–2.5
mg/L) with or without 0.5 mg/L 2,4-D. Callus from 3rd
generation  was  used  to  develop  cell-  suspension
culture  in  MS  liquid  medium  with  1  mg/L  TDZ.
Whereas  better  callus  production  and  their  fresh
weight  were  observed on the  lower range of  2,4-D
(0.1–0.5 mg/L), best callus maintenance was observed
on  1–1.5  mg/L  TDZ  without  2,4-D.  Gas
chromatography (GC) was performed and oil content
and  thymol  contents  were  analyzed  in  greenhouse
and  in-vitro grown  plants  and  calli  and  cell
suspension culture extracts. In-vitro grown plants  of
O. vulgare had the highest oil content in comparison
to  its  callus  and  cell  culture,  but  no  thymol  was
present.  In  O.  syriacum,  greenhouse-grown  plants
showed highest thymol percentage, and thymol was
not detected in calli or cell suspension culture. 
Another  report  (73),  also  utilized  leaf  explants
from  O.  vulgare,  O.  vulgare var.  hirtum and  O.
syriacum to develop callus cultures and compared the
extracts  of  farm-grown  plants  and  callus.  Explants
were  subjected  to  MS,  LS  or  B5  media  along  with
various  concentrations  and  combinations  of  2,4-D,
Kinetin, NAA and BAP. Out of the three media they
tested for callus production and growth, MS was the
best. A combination of 0.5 mg/L 2,4-D -5 mg/L Kinetin
and  0.5  mg/L  NAA-  3  mg/L  BAP  in  MS  produced
highest amount of callus. GC and GC -MS of extracts
showed the presence of 21 compounds in  O. vulgare
calli, 24 compounds in O. vulgare var. hirtum and 26
compounds  in  O.  syriacum calli.  Carvacrol  and  α-
pinene  were  detected  in  all  three  species.  Thymol
was  detected  only  in  O.  vulgare.  Carene-δ-2  was
found only in O. syriacum and O. vulgare. The results
obtained  by  later  study  (73)  were,  however,  in
contrast with earlier (72), who has not detected any
thymol in O. vulgare. 
Above  two  studies  provided  the  basis  that
Origanum callus  or  cell-suspension  culture  may  be
utilized  for  obtaining  active  constituents.
Nevertheless,  significant scope exists in establishing
the Origanum cell culture for enhanced production of
the desired metabolite in a controlled environment.
The  clones  with  higher  content(s)  and  genetic
engineering  for  improved  accumulation  will  be
relevant  to  the  needs of  pharmaceutical  industries.
Moreover,  it  will  reduce  the  overexploitation  of
Origanum spp.  from  nature  for  sourcing  the  plant
material.
Genetic transformation of Origanum spp.
Since the advent of genetic engineering of plants for
incorporating  useful  traits  not  available  in  their
germplasms  or  from  any  of  their  wild  relatives,  a
large number of plant species have been genetically
transformed with many genes to bring in those useful
traits in the transgenic plant lines, utilizing different
direct or indirect genetic transformation methods. In
spite  of  the  much-acclaimed  value  of  Origanum
medicinal herbs, unfortunately, no report exists that
detail  the standardization of genetic transformation
in  any  Origanum spp.;  nor  the  development  of  a
transgenic plant with a useful gene is reported in the
published literature. Although a study (65) reported
genetic  transformation  of  O.  vulgare with
Agrobacterium  rhizogenes and  regeneration  from
hairy root-derived callus,  their purpose was neither
development  of  transgenic  Oregano  nor
enhancing/tapping the secondary metabolite content
in O. vulgare hairy roots. The leaf explants from 20-25
days  old  oregano  plants  were  infected  with  two
strains  of  A.  rhizogenes. Bacterial  cells  were
harvested  at  OD600  nm of  0.8,  and  the  infection
medium contained MS salts with 50 mg/L sucrose. Six
co-cultivation media were tested, each containing MS
medium with 100 uM acetosyringone but lacking one
or more major or minor salt. After co-cultivation for
two days, explants were cultured in hormone-free MS
medium with 3% sucrose and 200 mg/L cefotaxime.
Both strains were found effective in inducing hairy
roots in oregano  explants  after  two weeks.  Highest
induction  (91.3%)  was  noted  on  co-cultivation
medium-5 (lacking KH2PO4, NH4NO3, KNO3 and CaCl2). 
For  transgenic  plant  development,  usually,  a
high-frequency  genetic  transformation  protocol  is
coupled to a reproducible in-vitro plant regeneration
system. Preferably, compatible A. tumefaciens strain-
binary vector system harbouring gene of interest is
required. Infected explants are cultured on selection
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medium  to  select  transformed  cells  which  can
eventually be subjected to regenerate into complete
plant  body.  Most  of  the  regeneration  protocol  in
Origanum  species  reported  so  far  utilizes
organogenesis  from  pre-existing  meristems,  and
generally,  meristem  based  regeneration  of
transformed cells lead to transgenic plants with the
chimeric organization. Thus it is necessary to develop
a compatible transformation-regeneration system in
Origanum spp. for homogeneous, stable and faithful
expression  of  the  transgene  in  all  the  cells  of
transformed regenerants. Further, the optimizations
of various factors affecting  A. tumefaciens -mediated
transformation are needed. 
Antiproliferative  properties:  Effects  of  extracts/
preparations from Origanum spp. on cytotoxicity
of cancer cells
Scientific investigation into anticancerous properties
of  Origanum phytoconstituents started with a study
in 1987 (17),  where  hydroquinone  isolated  from  O.
majorana was  demonstrated  to  have  potent
cytotoxicity  on  cultured  rat  hepatoma  cells  (HTC).
Whereas  this  initial  study  indicated  that  marjoram
constituents  have  antiproliferative  potential,  a
detailed  study  and  action  mechanisms  of  these
phytoconstituents  were presented by a  2010 report
(83).  The  antiproliferative  activity  of  ethanolic
extracts from marjoram leaves was tested on human
lymphoblastic  leukaemia  cell  line-Jurkat.  At  non-
cytotoxic  concentrations,  the  viability  of  cells
decreased  with  the  increase  of  plant  extract
concentration.  The  antiproliferative  effect  was  also
found to be dose-dependent. Marjoram extracts were
shown  to  stimulate  apoptosis,  which  in  turn  was
induced by an up-regulation of p53 protein levels and
down-regulation of Bcl-2α. The conclusions from this
study suggested that phenolic content-rich marjoram
extracts  exhibit  strong  antioxidant  and  scavenging
activities and high antiproliferative effect. 
O.  majorana and  O.  vulgare essential  oils  and
their  constituents  were  compared  for  cytotoxicity
against  different  cancer  cell  lines  (84).  In  the  MTT
assay,  O.  majorana  essential  oil  (OmEO)  was  more
cytotoxic than O. vulgare essential oil (OvEO) against
different cancer cell types, such as MCF-7, LNCaP and
NIH-3T3.  Another  study  (85)  reported  the  cytotoxic
activity  of  ethyl  acetate  and  ethanol  extracts  from
leaves of  O. compactum in human breast cancer cell
line – MCF7. 
The  anti-metastatic  and  anti-tumour  growth
effects  of  marjoram  ethanolic  extracts  on  highly
metastatic  human breast cancer cell  line-  MDA-MB-
231 was also presented (86), where it was shown that
O. majorana promotes inhibition of tumour growth
and  metastasis  in-vivo.  Ethanol  extract  from  O.
majorana  (87)  was  found  to  show  significant
cytotoxicity  (P<0.001)  to  fibrosarcoma  and  least
toxicity  to  normal  human  lymphocytes  when
compared  to  the  controls.  Ethanolic  extract  of  O.
syriacum was  shown  to  inhibit  human  leukaemia
THP-1 cells (18). In this work, ethanolic extracts from
aerial  parts  of  O. syriacum and  Thymus vulgaris  L.
were investigated  against  the  THP-1 leukaemia  cell
line  and  freshly  isolated  peripheral  blood
mononuclear cells (PBMCs). Both extracts exhibited a
concentration-dependent reduction in viability of the
THP-1 cells. However,  O. syriacum was more potent
against the PBMCs, while T. vulgaris was moderately
selective.  In  O.  syriacum the  reduction  in  cells
viability  was  caused  by  cytotoxic  effect  against
leukemic cells of THP-1. 
A  study  (88)  identified  71  compounds  in  the
essential  oil  obtained  by  hydrodistillation  of  aerial
parts of O. vulgare and tested both crude essential oil
(EO)  extract  as  well  as  single  substances  for
cytotoxicity  to carcinoma and non-tumour cell  line.
The  crude EO extract  has  significantly  reduced the
cell viability of the hepatocarcinoma cell line (HepG2)
in dose-dependent mode, as compared to the vehicle
control. Interestingly, results showed that oregano EO
has lower cytotoxic activity against non-tumour cell
line  HEK293.  While  testing  of  single  substances  for
cytotoxicity  against  HepG2  cells,  they  noted  that
carvacrol  and  citral  showed the  highest  significant
reduction of  cell  viability  of hepatocarcinoma cells.
Thymol and limonene showed a viability reduction of
HepG2 cells.
Aqueous,  petroleum  ether,  dichloromethane,
ethylacetate and methanol extracts were prepared from
aerial parts of marjoram, and these extracts were tested
(89) for cytotoxicity against breast cell line (MDA-MB-
231) and colon cancer cell line (HT-29 cells). All extracts
of O. majorana tested against both types of cancer cells
showed  a  more  pronounced  cytotoxic  effect  against
MDA-MB-231 than HT-29 cells.  In-vitro cytotoxic tests
showed that extracts inhibit the proliferation of human
cancer cell lines in a dose-dependent manner. Recently,
the  essential  oil  obtained  from  hydrodistillation  of
aerial parts of  O. onites  (OoEO) was examined for its
antiproliferative activity against melanoma cells (A375),
breast cancer cells  (MCF-7),  hepatocellular carcinoma
cells  (HepG2)  and  colon  cancer  cells  (HT-29)  (90).
Interestingly,  OoEO  exhibited  a  dose-dependent
antiproliferative activity against all human cancer cell
lines tested. The most potent antiproliferative effect was
observed in the HT-29 colon cancer cell line followed by
A375  skin  melanoma,  MCF-7  breast  carcinoma,  and
HepG2 hepatocellular carcinoma cells. OoEO attenuated
migration and induced apoptosis-related morphological
changes  in  both  human  (HT-29)  and  murine  (CT26)
colon cancer  cell  lines.  The  anticancerous  activity  of
ethanolic  extracts  prepared  from  dried  marjoram
leaves was also recently studied on two human colon
cancer  lines  (HT-29  and  Caco-2)  and  the  findings
provide strong evidence that O. majorana extract (OmE)
possesses  strong  anti-colon  cancer  potential,  at  least,
through  induction  of  autophagy  and  apoptosis  (19).
They showed that OmE exhibited this antiproliferative
activity  in  a  concentration-  and  time-dependent
manner.  OmE  inhibited  cell  viability,  colony  growth
and induced mitotic  arrest  of  HT-29 cells.  Also,  OmE
induced  DNA  damage,  triggered  abortive  autophagy
and activated  a caspase  3  and 7-dependent  extrinsic
apoptotic pathway, most likely through the activation of
the TNF-α pathway. The time-course analysis revealed
that DNA damage occurred concomitantly with abortive
autophagy 4 hours post-OmE treatment, while apoptosis
was activated only 24 hrs later. Blockade of autophagy
initiation (by 3-methyladenine) partially rescued OmE-
induced cell death.
All  the  works  mentioned above in  this  section
lead  to  some  generalizations:  (i)  Antiproliferative
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activity of  Origanum  is  concentration-dependent (in
the range which is non-cytotoxic to normal cells), (ii)
Although  Origanum phytoconstituents  have  strong
antioxidant  and  radical  scavenging  activity,  the
antiproliferative activity was shown to be mediated
through induction of  autophagy  and apoptosis.  (iii)
Many different cancer cell lines –HTC, HepG2, Jurkat,
THP-1,  MCF-7,  MDA-MB-231,  HT-29,  Caco-2,  A375,
LNCaP and NIH-3T3 have been tested to demonstrate
the anticancerous properties of phytoconstituents of
Origanum species, but still far from real practical use,
(iv) Mostly, crude extracts have been tested, but a few
have shown the efficacy of isolated constituents like
Carvacrol,  Citral  and Hydroquinone for cytotoxicity
of  cancerous  cells  and  (v)  O.  marjoram
phytoconstituents  have  been  mostly  used  to
demonstrate  this  cancer  cells  cytotoxicity,  followed
by  O.  vulgare;  however,  phytoconstituents  of  O.
syriacum, O. onites and O. compactum have also been
reported.
Conclusion
Scientific  investigations  into  medicinal  plants
nowadays  are  emphasizing  on  selecting  and
identifying  useful  compounds,  validating  their
individual or in combination efficacy as well as to
increase the production and availability  of source
material or plants. Origanum, with its many species
and multi-purpose medicinal value, has been found
to be an excellent source of such compounds. The
present  review  point  to  the  fact  that  significant
opportunities  exist  for  research  in  exploring  and
placing  the  therapeutic  potential  of  isolated
phytoconstituents, their consortia or crude extracts
of  Origanum species  in  designing  the  anticancer
medicines.  This  also  puts  forward a fiery need to
enhance  the  propagation  of  Origanum species
across  continents.  However,  the  literature  survey
reveals  the  research  gaps  in  standardized,  high-
frequency  in-vitro  regeneration  and  genetic
transformation  protocols  of  different  species  of
Origanum.  It  will  be  prudent  to  develop  somatic
embryogenesis  based  mass  propagation  methods
and  high-frequency  A.  tumefaciens-  mediated
transformation protocols for  Origanum spp. Model
genotypes  could  be  identified  which respond to  a
wider  range  of  regeneration  protocols,  or
regeneration  protocol  could  be  developed  which
perform  relatively  better  over  a  wider  range  of
Origanum genotypes.  The  lines  with  higher
contents  of  desired  constituents,  if  subjected  to
mass propagation,  will  boost industries  interested
in  Origanum compounds.  Origanum cell  culture
systems  need  to  be  developed,  and  metabolic
engineering  should  be  attempted  to  enhance  the
bioactive  secondary  metabolites.  In  this  context,
biotechnological efforts on these species are overly
underexploited,  keeping  in  view  ‘since  time
immemorial’  exploitation  of  this  culinarily  and
medicinally valuable plant species.
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